ZOLADEX DEPOT INJECTION 3.6 mg/syringe
Product details
Registration number: SIN01506P
Classification: Prescription Only
Active ingredients: GOSERELIN ACETATE EQV PEPTIDE
Strength: 3.6 mg/syringe
Dosage form: INJECTION
Route: SUBCUTANEOUS
Registrant: ASTRAZENECA SINGAPORE PTE LTD
ATC code: L02AE03
HSA approval date: 25 May 1988
Manufacturer(s): ASTRAZENECA UK LTD
Manufacturing country/countries: UNITED KINGDOM
What are the HSA registration number and classification for ZOLADEX DEPOT INJECTION 3.6 mg/syringe?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN01506P
Classification: Prescription Only
What active ingredients and strength are recorded for ZOLADEX DEPOT INJECTION 3.6 mg/syringe?
According to the HSA dataset updated 7 August 2026:
Active ingredients: GOSERELIN ACETATE EQV PEPTIDE
Strength: 3.6 mg/syringe
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ZOLADEX DEPOT INJECTION 3.6 mg/syringe?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: SUBCUTANEOUS
Who is the recorded registrant for ZOLADEX DEPOT INJECTION 3.6 mg/syringe?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTRAZENECA SINGAPORE PTE LTD
Which manufacturers and countries are listed for ZOLADEX DEPOT INJECTION 3.6 mg/syringe?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): ASTRAZENECA UK LTD
Manufacturing country/countries: UNITED KINGDOM
Where can I look up ZOLADEX DEPOT INJECTION 3.6 mg/syringe in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN01506P or the exact product name ZOLADEX DEPOT INJECTION 3.6 mg/syringe. The general register link does not preselect this product.
What are the source dates for this ZOLADEX DEPOT INJECTION 3.6 mg/syringe record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ZOLADEX DEPOT INJECTION 3.6 mg/syringe record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN01506P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)